The Interactive Antimicrobial Activity of Glycyrrhiza glabra L. Root Extracts and Conventional Antibiotics Against some Bacterial Triggers of Autoimmune Inflammatory Diseases

groupview

Abstract
Pharmacognosy Communications,2018,8,2,xx-xx.
Published:April 2018
Type:Original Article

The Interactive Antimicrobial Activity of Glycyrrhiza glabra L. Root Extracts and Conventional Antibiotics Against some Bacterial Triggers of Autoimmune Inflammatory Diseases

Haydon Maas1, Ian Edwin Cock1,2*

1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

2Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

Abstract:

Background: Roots from Glycyrrhiza glabra L. are known for their anti-inflammatory and antimicrobial properties. This study focuses on the growth inhibitory activity of G. glabra root extracts against some bacterial triggers of autoimmune inflammatory disease alone and in combination with conventional antibiotics. Methods: G. glabra root powder was extracted with solvents of varying polarity and screened for bacterial growth inhibition by disc diffusion assay. The minimum inhibitory concentration (MIC) was quantified by both liquid dilution and disc diffusion techniques. To screen for combinatorial effects, the G. glabra root extracts were combined with a range of conventional antibiotics and tested against each bacterium using liquid dilution assays. Where synergy was detected, the optimal ratios were determined using isobologram analysis. Toxicity was examined using an Artemia nauplii and HDF bioassays. Results: G. glabra root methanolic, aqueous and ethyl acetate extracts displayed antimicrobial activity against bacterial triggers of some autoimmune inflammatory diseases. The ethyl acetate extract was particularly potent, with MIC values <500 μg/mL against K. pneumoniae and A. baylyi. The aqueous extract was also a moderate inhibitor of A. baylyi. The methanolic extract had moderate inhibitory activity against all bacteria except P. aeruginosa. Of further note, the aqueous extract interacted synergistically in combination with chloramphenicol against K. pneumoniae (Σ FIC 0.49). All extracts were nontoxic in the Artemia and HDF toxicity assays, further indicating their potential for medicinal use. Conclusions: The G. glabra ethyl acetate root extract was a strong inhibitor of the growth of K. pneumoniae and A. baylyi and therefore have potential in the prevention and treatment of ankylosing spondylitis and multiple sclerosis. In addition, the aqueous root extract potentiated the inhibitory activity of chloramphenicol against a chloramphenicol resistant K. pneumoniae strain. Although the mechanisms of synergy are still unclear, compounds within the G. glabra root extracts may mimic the actions of resistance modifying agents. Isolation of these agents may be beneficial in antibiotic drug design against bacterial triggers of ankylosing spondylitis.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.